drugset
drugset / Trial / NCT03512821

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

NCT03512821 ↗

Phase 1 Completed 77 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

single-dose, comparative bioavailability study of two formulations of ursodiol 500mg tablets under fed conditions

Timeline

Start
2017-10-01
Primary completion
2017-11-30
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ursodeoxycholic Acid Small molecule 500 mg —

Indications

No indication recorded.